Researchers at the University of California, San Diego have developed a systemic gene therapy, SynCav1, that successfully shields neurons from the cognitive and structural damage caused by TDP-43 proteinopathy in …
@2025 – Hosted by ByoHosting – Most Recommendeed Webhhosting. For complains, abuse, advertising contact: office@byohosting.com